McKesson's stock appears undervalued, trading at 18 times forward earnings and free cash flow. See why MCK is a Hold.

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

We recently published a list of 10 Firms Dominate Monday Upsurge. In this article, we are going to take a look at where CVS ...

CVS faces significant 2025 headwinds, including intense pharmacy competition, threatened new federal government pressures, ...

Shares of CVS Health Corp. CVS advanced 1.11% to $52.14 Wednesday, on what proved to be an all-around favorable trading ...

Shares of CVS Health Corp. CVS inched 0.10% higher to $51.57 Tuesday, on what proved to be an all-around positive trading ...

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...

This week's dividend activity included increased payouts from Lakeland Financial (LKFN) and Valero Energy (VLO) as well as ...

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.